Organ Failure Avoidance and Mitigation Strategies in Surgery

Surgical Clinics of North America

Volumn 92, Issue 2, 2012, Pages 307-319

  McConnell, Kevin W ^a   Coopersmith, Craig M ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Critical care; Organ failure; Resuscitation; Sepsis

Indexed keywords

HYPERTENSIVE FACTOR; NEUROMUSCULAR BLOCKING AGENT; NORADRENALIN; SEDATIVE AGENT;

ACUTE KIDNEY FAILURE; ANESTHESIST; ATELECTASIS; BLOOD PRESSURE REGULATION; DELIRIUM; ENTERIC FEEDING; HIGH RISK PATIENT; HUMAN; HYPOVOLEMIA; INTENSIVE CARE; LUNG INJURY; MEAN ARTERIAL PRESSURE; MULTIPLE ORGAN FAILURE; PALLIATIVE THERAPY; PATIENT IDENTIFICATION; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RESPONSIBILITY; RESUSCITATION; REVIEW; RISK BENEFIT ANALYSIS; SCORING SYSTEM; SEDATION; SHOCK; STEROID THERAPY; SURGEON; SURGICAL RISK; TENSION PNEUMOTHORAX; TOTAL PARENTERAL NUTRITION;

HUMANS; MULTIPLE ORGAN FAILURE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURGICAL PROCEDURES, OPERATIVE;

EID: 84858146227     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2012.01.001     Document Type: Review

References (93)

1. Skillman J.J., Bushnell L.S., Goldman H., et al. Respiratory failure, hypotension, sepsis, and jaundice. A clinical syndrome associated with lethal hemorrhage from acute stress ulceration of the stomach. Am J Surg 1969, 117(4):523-530.
2. Baue A.E. Multiple, progressive, or sequential systems failure. A syndrome of the 1970s. Arch Surg 1975, 110(7):779-781.
3. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20(6):864-874.
4. Barie P.S., Hydo L.J. Epidemiology of multiple organ dysfunction syndrome in critical surgical illness. Surg Infect 2000, 1(3):173-185. [discussion: 185-6].
5. Martin C.M., Hill A.D., Burns K., et al. Characteristics and outcomes for critically ill patients with prolonged intensive care unit stays. Crit Care Med 2005, 33(9):1922-1927. [quiz: 1936].
6. Vincent J.L., Sakr Y., Sprung C.L., et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006, 34(2):344-353.
7. Dewar D., Moore F.A., Moore E.E., et al. Postinjury multiple organ failure. Injury 2009, 40(9):912-918.
8. Martin G.S., Mannino D.M., Eaton S., et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348(16):1546-1554.
9. Barie P.S., Hydo L.J., Pieracci F.M., et al. Multiple organ dysfunction syndrome in critical surgical illness. Surg Infect 2009, 10(5):369-377.
10. Kallinen O., Maisniemi K., Bohling T., et al. Multiple organ failure as a cause of death in patients with severe burns. J Burn Care Res 2011, [Epub ahead of print].
11. Marshall J.C., Cook D.J., Christou N.V., et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995, 23(10):1638-1652.
12. Le Gall J.R., Klar J., Lemeshow S., et al. The Logistic Organ Dysfunction System. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA 1996, 276(10):802-810.
13. Hotchkiss R.S., Opal S. Immunotherapy for sepsis-a new approach against an ancient foe. N Engl J Med 2010, 363(1):87-89.
14. Vincent J.L., Martinez E.O., Silva E. Evolving concepts in sepsis definitions. Crit Care Nurs Clin North Am 2011, 23(1):29-39.
15. Marshall J.C. Sepsis research: where have we gone wrong?. Crit Care Resusc 2006, 8(3):241-243.
16. Carlet J., Cohen J., Calandra T., et al. Sepsis: time to reconsider the concept. Crit Care Med 2008, 36(3):964-966.
17. Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31(4):1250-1256.
18. Ferreira A.M., Sakr Y. Organ dysfunction: general approach, epidemiology, and organ failure scores. Semin Respir Crit Care Med 2011, 32(5):543-551.
19. Coopersmith C.M., Stromberg P.E., Dunne W.M., et al. Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 2002, 287(13):1716-1721.
20. Marshall J.C. Modeling MODS: what can be learned from animal models of the multiple-organ dysfunction syndrome?. Intensive Care Med 2005, 31(5):605-608.
21. Dorinsky P.M., Gadek J.E. Mechanisms of multiple nonpulmonary organ failure in ARDS. Chest 1989, 96(4):885-892.
22. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348(2):138-150.
23. Paulus P., Jennewein C., Zacharowski K. Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis?. Biomarkers 2011, 16(Suppl 1):S11-S21.
24. Fink M.P. Gastrointestinal mucosal injury in experimental models of shock, trauma, and sepsis. Crit Care Med 1991, 19(5):627-641.
25. Marshall J.C. Neutrophils in the pathogenesis of sepsis. Crit Care Med 2005, 33(Suppl 12):S502-S505.
26. Patel K.N., Soubra S.H., Lam F.W., et al. Polymicrobial sepsis and endotoxemia promote microvascular thrombosis via distinct mechanisms. J Thromb Haemostasis 2010, 8(6):1403-1409.
27. Dixon B. The role of microvascular thrombosis in sepsis. Anaesth Intensive Care 2004, 32(5):619-629.
28. Suliburk J., Helmer K., Moore F., et al. The gut in systemic inflammatory response syndrome and sepsis. Enzyme systems fighting multiple organ failure. Eur Surg Res 2008, 40(2):184-189.
29. Marshall J.C. Critical illness is an iatrogenic disorder. Crit Care Med 2010, 38(Suppl 10):S582-S589.
30. Ranieri V.M., Suter P.M., Tortorella C., et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 1999, 282(1):54-61.
31. Imai Y., Parodo J., Kajikawa O., et al. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA 2003, 289(16):2104-2112.
32. Fleisher L.A., Beckman J.A., Brown K.A., et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007, 116(17):e418-e499.
33. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36(1):296-327.
34. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000, 342(18):1301-1308.
35. Ely E.W., Shintani A., Truman B., et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004, 291(14):1753-1762.
36. Ely E.W., Inouye S.K., Bernard G.R., et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001, 286(21):2703-2710.
37. Riker R.R., Shehabi Y., Bokesch P.M., et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009, 301(5):489-499.
38. Pichot C., Ghignone M., Quintin L. Dexmedetomidine and clonidine: from second-to-first-line sedative agents in the critical care setting?. J Intensive Care Med 2011, [Epub ahead of print].
39. Brook A.D., Ahrens T.S., Schaiff R., et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999, 27(12):2609-2615.
40. MacLaren R., Plamondon J.M., Ramsay K.B., et al. A prospective evaluation of empiric versus protocol-based sedation and analgesia. Pharmacotherapy 2000, 20(6):662-672.
41. Girard T.D., Kress J.P., Fuchs B.D., et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled Trial): a randomised controlled trial. Lancet 2008, 371(9607):126-134.
42. Devlin J.W., Boleski G., Mlynarek M., et al. Motor Activity Assessment Scale: a valid and reliable sedation scale for use with mechanically ventilated patients in an adult surgical intensive care unit. Crit Care Med 1999, 27(7):1271-1275.
43. De Jonghe B., Sharshar T., Lefaucheur J.P., et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002, 288(22):2859-2867.
44. Papazian L., Forel J.M., Gacouin A., et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010, 363(12):1107-1116.
45. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345(19):1368-1377.
46. Bourgoin A., Leone M., Delmas A., et al. Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med 2005, 33(4):780-786.
47. De Backer D., Biston P., Devriendt J., et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010, 362(9):779-789.
48. Stewart T.E., Meade M.O., Cook D.J., et al. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. Pressure- and Volume-Limited Ventilation Strategy Group. N Engl J Med 1998, 338(6):355-361.
49. Tobin M.J. Culmination of an era in research on the acute respiratory distress syndrome. N Engl J Med 2000, 342(18):1360-1361.
50. Marini J.J., Gattinoni L. Ventilatory management of acute respiratory distress syndrome: a consensus of two. Crit Care Med 2004, 32(1):250-255.
51. Brower R.G., Lanken P.N., MacIntyre N., et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004, 351(4):327-336.
52. Amato M.B., Barbas C.S., Medeiros D.M., et al. Beneficial effects of the " open lung approach" with low distending pressures in acute respiratory distress syndrome. A prospective randomized study on mechanical ventilation. Am J Respir Crit Care Med 1995, 152(6 Pt 1):1835-1846.
53. Kollef M.H. Prevention of hospital-associated pneumonia and ventilator-associated pneumonia. Crit Care Med 2004, 32(6):1396-1405.
54. Ely E.W., Baker A.M., Dunagan D.P., et al. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 1996, 335(25):1864-1869.
55. Esteban A., Alia I., Tobin M.J., et al. Effect of spontaneous breathing trial duration on outcome of attempts to discontinue mechanical ventilation. Spanish Lung Failure Collaborative Group. Am J Respir Crit Care Med 1999, 159(2):512-518.
56. Esteban A., Alia I., Gordo F., et al. Extubation outcome after spontaneous breathing trials with T-tube or pressure support ventilation. The Spanish Lung Failure Collaborative Group. Am J Respir Crit Care Med 1997, 156(2 Pt 1):459-465.
57. Flori H.R., Church G., Liu K.D., et al. Positive fluid balance is associated with higher mortality and prolonged mechanical ventilation in pediatric patients with acute lung injury. Crit Care Res Pract 2011, 2011:854142.
58. Wiedemann H.P., Wheeler A.P., Bernard G.R., et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006, 354(24):2564-2575.
59. Wheeler A.P., Bernard G.R., Thompson B.T., et al. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 2006, 354(21):2213-2224.
60. Sandham J.D., Hull R.D., Brant R.F., et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 2003, 348(1):5-14.
61. Richard C., Warszawski J., Anguel N., et al. Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2003, 290(20):2713-2720.
62. Bagshaw S.M., Lapinsky S., Dial S., et al. Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med 2009, 35(5):871-881.
63. ACT Investigators Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation 2011, 124(11):1250-1259.
64. Myburgh J., Cooper D.J., Finfer S., et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007, 357(9):874-884.
65. Martin G.S., Mangialardi R.J., Wheeler A.P., et al. Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med 2002, 30(10):2175-2182.
66. Delaney A.P., Dan A., McCaffrey J., et al. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med 2011, 39(2):386-391.
67. Yunos N.M., Kim I.B., Bellomo R., et al. The biochemical effects of restricting chloride-rich fluids in intensive care. Crit Care Med 2011, 39(11):2419-2424.
68. Ricci Z., Polito A., Ronco C. The implications and management of septic acute kidney injury. Nat Rev Nephrol 2011, 7(4):218-225.
69. Honore P.M., Jacobs R., Joannes-Boyau O., et al. Septic AKI in ICU patients. diagnosis, pathophysiology, and treatment type, dosing, and timing: a comprehensive review of recent and future developments. Ann Intensive Care 2011, 1(1):32.
70. Oda S., Sadahiro T., Hirayama Y., et al. Non-renal indications for continuous renal replacement therapy: current status in Japan. Contrib Nephrol 2010, 166:47-53.
71. Clark J.A., Coopersmith C.M. Intestinal crosstalk: a new paradigm for understanding the gut as the " motor" of critical illness. Shock 2007, 28(4):384-393.
72. Moore F.A., Moore E.E., Kudsk K.A., et al. Clinical benefits of an immune-enhancing diet for early postinjury enteral feeding. J Trauma 1994, 37(4):607-615.
73. Moore F.A., Feliciano D.V., Andrassy R.J., et al. Early enteral feeding, compared with parenteral, reduces postoperative septic complications. The results of a meta-analysis. Ann Surg 1992, 216(2):172-183.
74. Moore F.A., Moore E.E., Jones T.N., et al. TEN versus TPN following major abdominal trauma-reduced septic morbidity. J Trauma 1989, 29(7):916-922. [discussion: 922-3].
75. Kudsk K.A., Croce M.A., Fabian T.C., et al. Enteral versus parenteral feeding. Effects on septic morbidity after blunt and penetrating abdominal trauma. Ann Surg 1992, 215(5):503-511. [discussion: 511-3].
76. Casaer M.P., Mesotten D., Hermans G., et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med 2011, 365(6):506-517.
77. Available at: Accessed August 1, 2011. http://www.criticalcarenutrition.com/docs/cpg/srrev.pdf.
78. Vanhorebeek I., Langouche L., Van den Berghe G. Endocrine aspects of acute and prolonged critical illness. Nat Clin Pract Endocrinol Metab 2006, 2(1):20-31.
79. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345(19):1359-1367.
80. Finfer S., Chittock D.R., Su S.Y., et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360(13):1283-1297.
81. Griesdale D.E., de Souza R.J., van Dam R.M., et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009, 180(8):821-827.
82. Marik P.E., Preiser J.C. Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest 2010, 137(3):544-551.
83. Annane D., Sebille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288(7):862-871.
84. Sprung C.L., Annane D., Keh D., et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358(2):111-124.
85. Hebert P.C., Wells G., Blajchman M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999, 340(6):409-417.
86. Napolitano L.M., Kurek S., Luchette F.A., et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med 2009, 37(12):3124-3157.
87. Available at: Accessed August 1, 2011. http://clinicaltrials.gov/ct2/show/NCT00510835%3Fterm=process%26rank=1.
88. Iregui M., Ward S., Sherman G., et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002, 122(1):262-268.
89. Dickinson J.D., Kollef M.H. Early and adequate antibiotic therapy in the treatment of severe sepsis and septic shock. Curr Infect Dis Rep 2011, 13(5):399-405.
90. Laterre P.F., Abraham E., Janes J.M., et al. ADDRESS (ADministration of DRotrecogin alfa [activated] in Early stage Severe Sepsis) long-term follow-up: one-year safety and efficacy evaluation. Crit Care Med 2007, 35(6):1457-1463.
91. Dhainaut J.F., Laterre P.F., Janes J.M., et al. Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial. Intensive Care Med 2003, 29(6):894-903.
92. Rubulotta F., Marshall J.C., Ramsay G., et al. Predisposition, insult/infection, response, and organ dysfunction: a new model for staging severe sepsis. Crit Care Med 2009, 37(4):1329-1335.
93. Moreno R.P., Metnitz B., Adler L., et al. Sepsis mortality prediction based on predisposition, infection and response. Intensive Care Med 2008, 34(3):496-504.